Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMF PK/PD in Pediatric HSCT
NCT04868786Phase 1Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Oct 2020
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mycophenolate mofetil in graft-versus-host disease (GVHD), sponsored by Seoul National University Hospital. Primary endpoint: Pharmacokinetics parameters of mycophenolate mofetil. Status: unknown.
02
Drugs
mycophenolate mofetil
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT04868786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04868786.